IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital Management LP

Q3 2020 Holdings

Filed 2020-11-12 | 15 holdings | $151.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BridgeBio Pharma Inc (Bbio)(BBIO)COM10806X102$149.7M3,989,41298.8%
Aclaris Therapeutics Inc (Acrs)(ACRS)COM00461U105$1.6M634,4551.1%
Eidos Therapeutics, Inc. (Eidix)(EIDXGBP)COM28249H104$56.8K1,123,6300.0%
Harmony Biosciences Hldgs in (Hrmy)(HRMY)COM413197104$28.6K842,8150.0%
Syndax Pharmaceuticals, Inc. (Sndx)(SNDX)COM87164F105$15.1K1,025,0000.0%
Avrobio, Inc. (Avro)COM05455M100$13.1K1,009,7790.0%
Aeglea Biotherapeutics Inc (Agle)(AGLEUSD)COM00773J103$12.0K1,691,1510.0%
Poseida Therapeutics Inc (Pstx)(PSTXUSD)COM73730P108$9.3K1,043,2670.0%
Verona Pharma plc (Vrna)(VRNA)COM925050106$8.3K1,332,4850.0%
Atreca Inc (Bcel)(BCELUSD)CL A COM04965G109$5.4K387,6530.0%
Zosano Pharma Corporation (Zsan)COM98979H202$4.4K2,718,2260.0%
ObsEva SA (Obsv)COMH5861P103$3.4K1,386,3380.0%
Marker Therapeutics, Inc. (Mrkr)COM57055L107$3.0K2,000,0000.0%
Sunesis Pharmaceuticals, Inc. (Snss)COM867328700$1.3K1,010,0000.0%
Nabriva Therapeutics plc (Nbrv)SHSG63637105$1.0K1,910,2870.0%